Bell Investment Advisors, Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Bell Investment Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$1.06 - $1.67 $420 - $662	-397 Reduced 55.68%	316 $0
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $2,588 - $3,676	-2,054 Reduced 74.23%	713 $1,000
Q3 2023 Nov 08, 2023	SELL	$1.61 - $2.54 $201 - $317	-125 Reduced 4.32%	2,767 $5,000
Q2 2023 Aug 09, 2023	BUY	$1.14 - $1.95 $64 - $111	57 Added 2.01%	2,892 $5,000
Q1 2023 May 10, 2023	SELL	$1.2 - $2.19 $334 - $611	-279 Reduced 8.96%	2,835 $3,000
Q4 2022 Feb 08, 2023	BUY	$1.63 - $3.52 $1,630 - $3,520	1,000 Added 47.3%	3,114 $5,000
Q3 2022 Nov 09, 2022	BUY	$0.73 - $3.74 $889 - $4,559	1,219 Added 136.2%	2,114 $7,000
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $1,969 - $3,759	895 New	895 $2,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.